Investment Risk Influencing Factors Research On China's Biological Pharmacy Listed Companies

Biological pharmacy industry is one of the fastest developing industries inHigh-tech industry. It has attractive investment outlook and huge investmentpotential. As an high concentration of technology project, biological pharmacyindustry has a lot of characteristics,such as high technology request, largenumber of fund occupation and much uncertain element. The risk in itsinvestment is difficult to forecast, so some companies suffered from huge lossas a result of ignoring the risk assessment or using improper assessment methodin investment. In order to reduce the investment risk and reduce the loss, wemust calculate the risk accurately before investing. Therefore, it is verynecessary to provide theoretical basis for investors to make evaluationinvestment risk of biology pharmacy industry of our country correctly andobjectively, and to make a better selection of investment area and investmentopportunity, using scientific projects investment risk evaluation method.In this paper, the research can be separated into the following aspects: firstly,research background, research significance, internal and external researchpresent situation, main content and research methods are introduced in detail;secondly, I analysis the external influencing factor of china's biologicalpharmacy listed companies investment risk quantitatively. With features ofchina's biological pharmacy industry and risk investment, I construct a systemof external influence factors of Chinese pharmaceutical listed companyinvesting risk. On the basis of this system, combining AHP method and Fuzzyevaluation method, I fix the weight and assess the situation of the influencefactors; and then, I research the internal influencing factor of china's biologicalpharmacy listed companies investing risk. With features of internal influencefactors of listed companies, from the view of risk and return, I construct asystem of investment risk evaluation indexes. In this paper, I take31biologicalpharmacy listed companies whose main business is biological pharmacy asresearch examples, and evaluate investment risk of the research examples byprincipal component-cluster analysis method. According to different rate of risk, I sort and classify these companies simply; In the end, I point out the problem ofbiological pharmacy industry investing environment of our country, and pointout the guarding countermeasure and advice in accordance with these problems.